Trial Profile
Clobetasol 0.05% spray in patients with moderate-to-severe plaque psoriasis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2012
Price :
$35
*
At a glance
- Drugs Clobetasol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 06 Apr 2012 New trial record
- 20 Mar 2012 Results assessing the effects of treatment on plaque psoriasis signs presented at the 70th Annual Meeting of the American Academy of Dermatology.